83 related articles for article (PubMed ID: 7562531)
1. Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats.
Díaz A; Ruíz F; Flórez J; Pazos A; Hurlé MA
J Pharmacol Exp Ther; 1995 Sep; 274(3):1538-44. PubMed ID: 7562531
[TBL] [Abstract][Full Text] [Related]
2. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system.
Diaz A; Ruiz F; Flórez J; Hurlé MA; Pazos A
J Pharmacol Exp Ther; 1995 Sep; 274(3):1545-51. PubMed ID: 7562532
[TBL] [Abstract][Full Text] [Related]
3. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system.
Díaz A; Flórez J; Pazos A; Hurlé MA
Pain; 2000 Jun; 86(3):227-235. PubMed ID: 10812252
[TBL] [Abstract][Full Text] [Related]
4. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
5. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
Hurlé MA
J Neurochem; 2001 Apr; 77(2):486-92. PubMed ID: 11299311
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the cyclic AMP system in the switch from tolerance into supersensitivity to the antinociceptive effect of the opioid sufentanil.
Hurlé MA; Goirigolzarri I; Valdizán EM
Br J Pharmacol; 2000 May; 130(1):174-80. PubMed ID: 10781014
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dihydropyridine-sensitive Ca(2+) channels during naloxone-induced opioid supersensitivity in rats.
Gullapalli S; Ramarao P
Eur J Pharmacol; 2002 Sep; 451(3):271-7. PubMed ID: 12242088
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic mapping of mu-opioid receptors during opiate tolerance and supersensitivity in the rat central nervous system.
Díaz A; Pazos A; Flórez J; Hurlé MA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):101-9. PubMed ID: 10961371
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine is more effective than nifedipine in attenuating morphine tolerance on chronic co-administration in the rat tail-flick test.
Ray SB; Mishra P; Verma D; Gupta A; Wadhwa S
Indian J Exp Biol; 2008 Apr; 46(4):219-28. PubMed ID: 18512330
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions.
Dierssen M; Flórez J; Hurlé MA
Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):559-65. PubMed ID: 1708855
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic administration of dihydropyridine Ca2+ channel ligands on sufentanil-induced tolerance to mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Laorden ML; Milanés MV
Regul Pept; 1996 May; 63(1):1-8. PubMed ID: 8795082
[TBL] [Abstract][Full Text] [Related]
12. Kappa-opioid receptor mediated antinociception in rats is dependent on the functional state of dihydropyridine-sensitive calcium channels.
Barro M; Ruiz F; Hurlé MA
Brain Res; 1995 Feb; 672(1-2):148-52. PubMed ID: 7749736
[TBL] [Abstract][Full Text] [Related]
13. Opiate analgesia and calcium channels modulation by dihydropyridines under acute and tolerant conditions.
Flórez J; Dierssen M; Hurlé MA
Prog Clin Biol Res; 1990; 328():461-4. PubMed ID: 1689496
[No Abstract] [Full Text] [Related]
14. Chronic morphine treatment decreases the Cav1.3 subunit of the L-type calcium channel.
Haller VL; Bernstein MA; Welch SP
Eur J Pharmacol; 2008 Jan; 578(2-3):101-7. PubMed ID: 18048029
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
16. Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine.
Yamada S; Uchida S; Ohkura T; Kimura R; Yamaguchi M; Suzuki M; Yamamoto M
J Pharmacol Exp Ther; 1996 May; 277(2):721-7. PubMed ID: 8627551
[TBL] [Abstract][Full Text] [Related]
17. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
Arun KH; Kaul CL; Ramarao P
Cardiovasc Res; 2005 Feb; 65(2):374-86. PubMed ID: 15639476
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats.
Ruiz F; Dierssen M; Flórez J; Hurlé MA
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):633-7. PubMed ID: 8133906
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
[TBL] [Abstract][Full Text] [Related]
20. Effects of intrathecal L- and N-type calcium channel blockers on the antinociception evoked by opioid agonists in the rat tail flick test.
Lia EN; Prado WA
Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):195-203. PubMed ID: 10797861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
